Back to Search
Start Over
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials
- Source :
- The Lancet Haematology; June 2020, Vol. 7 Issue: 6 pe447-e455, 9p
- Publication Year :
- 2020
-
Abstract
- Daratumumab showed encouraging efficacy as monotherapy in patients with heavily pretreated multiple myeloma in the GEN501 and SIRIUS studies. Here we report a pooled, post-hoc final analysis of these two studies.
Details
- Language :
- English
- ISSN :
- 23523026
- Volume :
- 7
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- The Lancet Haematology
- Publication Type :
- Periodical
- Accession number :
- ejs54439934
- Full Text :
- https://doi.org/10.1016/S2352-3026(20)30081-8